We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » In Head-to-Head, Trial Generic Lipitor Edges Out Crestor
In Head-to-Head, Trial Generic Lipitor Edges Out Crestor
September 14, 2011
AstraZeneca’s leading cholesterol drug, Crestor, failed to show statistically significant benefit over Pfizer’s Lipitor, according to top-line results of a Phase IIIb trial.